Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,108 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,158)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06630351 | Group Meaning-Centered Psychotherapy for the Improvement of Wellbeing in Caregivers of Patients With Serious Illness | enrolling by invitation | N/A | 80 | Mayo ClinicOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT05600933 | Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment | enrolling by invitation | — | 1,200 | National Cancer Institute (NCI)NIH | 1 | Aug 6, 2026 |
| NCT05879211 | Goal Concordant Care Learning Laboratory | enrolling by invitation | N/A | 5,000 | Duke UniversityOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06157671 | The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma | enrolling by invitation | — | 1,000 | Adenocyte, LLCINDUSTRY | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06276764 | The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas) | enrolling by invitation | — | 500 | Adenocyte, LLCINDUSTRY | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06113315 | A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy | enrolling by invitation | — | 250 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT06701201 | A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product | enrolling by invitation | — | 60 | Verismo TherapeuticsINDUSTRY | 1 | Aug 4, 2026 | clinicaltrials |
| NCT07713901 | Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma | enrolling by invitation | — | 93,600,000 | Novo Nordisk A/SINDUSTRY | 1 | Aug 4, 2026 | clinicaltrials |
| NCT06680596 | Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy(SAFIR3LibHERty) | enrolling by invitation | Phase 2 | 80 | UNICANCEROTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07741006 | Clinical Evaluation of [68Ga]Ga-ELI411 PET Imaging in Adult Patients With Solid Tumors | enrolling by invitation | Early Phase 1 | 18 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07741058 | AI-Augmented Diagnostic Assessment With ENLIGHT Versus Independent Pathologist Review(ENLIGHT) | enrolling by invitation | N/A | 25 | Harvard Medical School (HMS and HSDM)OTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT03689595 | Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE) | enrolling by invitation | — | 30,000 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT05669989 | International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab | enrolling by invitation | Phase 2 | 70 | SanofiINDUSTRY | 17 | Jul 31, 2026 | clinicaltrials |
| NCT05673551 | VR-PAT During Home Burn Dressings - Multisite | enrolling by invitation | N/A | 220 | Nationwide Children's HospitalOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT06458998 | Getting To Implementation: Improving Cancer Screening for Veterans(GTI) | enrolling by invitation | N/A | 30,300 | University of PittsburghOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT07738367 | Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC | enrolling by invitation | Phase 2 | 20 | Fujian Cancer HospitalOTHER_GOV | 1 | Jul 31, 2026 | clinicaltrials |
| NCT06604130 | Plasma Exosome RNA to Diagnose Prostate Cancer(exo-PRECISE) | enrolling by invitation | N/A | 1,600 | Xijing HospitalOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07517666 | Genetic Information for Families After Tumor Testing Study(GIFTT) | enrolling by invitation | N/A | 100 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT04093570 | A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) | enrolling by invitation | Phase 2 | 332 | Taiho Oncology, Inc.INDUSTRY | 13 | Jul 28, 2026 | clinicaltrials |
| NCT00102544 | Use of Tracking Devices to Locate Abnormalities During Invasive Procedures | enrolling by invitation | N/A | 3,894 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jul 24, 2026 | clinicaltrials |
| NCT06412029 | Understanding and Enhancing Health-Related Social Needs (HRSN) Screening Among Community Oncology Practices(HRSN) | enrolling by invitation | — | 144 | Wake Forest University Health SciencesOTHER | 3 | Jul 24, 2026 | clinicaltrials |
| NCT07373899 | Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study | enrolling by invitation | — | 354 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT05407844 | Community Health Worker Based Intervention to Improve Palliative Care(DeCIDE PC) | enrolling by invitation | N/A | 160 | Wake Forest University Health SciencesOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07724028 | Neurovascular Bundle Stimulation During Robot-Assisted Radical Prostatectomy(NVB Stym-RARP) | enrolling by invitation | N/A | 20 | University Medical Centre LjubljanaOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT06678828 | Clinical Utility of ClarityDX Prostate | enrolling by invitation | N/A | 1,450 | NanosticsINDUSTRY | 1 | Jul 22, 2026 | clinicaltrials |
| NCT04254133 | Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study(GIFTS) | enrolling by invitation | — | 1,360 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT04364503 | Compliant Analysis of Patient Samples and Data | enrolling by invitation | — | 2,000 | Sequenom, Inc.INDUSTRY | 1 | Jul 21, 2026 | clinicaltrials |
| NCT06767475 | Mindfulness-Based Stress Reduction to Improve Well-being in Black Adult Cancer Survivors, Community Faith-based Mindfulness Ministry(ComFaMM) | enrolling by invitation | N/A | 65 | Mayo ClinicOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07234539 | Evaluation of an Artificial Intelligence-enabled Clinical Assistant to Support Thyroid Cancer Management | enrolling by invitation | N/A | 76 | The University of Hong KongOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07532928 | A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data | enrolling by invitation | — | 571 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT00923442 | Biology Studies of Hematologic Cancers | enrolling by invitation | — | 550 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2026 | clinicaltrials |
| NCT02315599 | Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials | enrolling by invitation | — | 500 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07708012 | Clinical Study on Using Laparoscopic Sentinel Lymph Node Navigation Combined With Dual Endoscopy Surgery for Early Gastric Cancer | enrolling by invitation | N/A | 30 | wangdongshengOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07703735 | Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma(HCC) | enrolling by invitation | — | 371 | Seoung Hoon KimOTHER_GOV | 0 | Jul 14, 2026 | clinicaltrials |
| NCT04996706 | Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study(LEO) | enrolling by invitation | — | 21,000 | Mayo ClinicOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT06424626 | A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma | enrolling by invitation | Phase 1 | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT06848088 | A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment | enrolling by invitation | Phase 2 | 48 | Regeneron PharmaceuticalsINDUSTRY | 2 | Jul 13, 2026 | clinicaltrials |
| NCT07693647 | Evaluation of Pelvic Floor Function and Psychosocial Sequelae Following Radical Prostatectomy for Prostate Cancer | enrolling by invitation | — | 67 | University of ValenciaOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT07697170 | Frequency of Care for Peripherally Inserted Central Vascular Access In the Prevention of Marsi(ICO-MARSI) | enrolling by invitation | N/A | 150 | Institut Català d'OncologiaOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT06834204 | Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors(ACCESS-PC) | enrolling by invitation | N/A | 266 | Rutgers, The State University of New JerseyOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT06769087 | Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery(POUR) | enrolling by invitation | N/A | 316 | Seoul St. Mary's HospitalOTHER | 1 | Jul 9, 2026 | clinicaltrials |
| NCT07690761 | Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant(Rituximab+ Zan) | enrolling by invitation | Phase 2 | 12 | Bnai Zion Medical CenterOTHER_GOV | 1 | Jul 8, 2026 | clinicaltrials |
| NCT07683195 | Research on Early Recurrence of Locally Advanced Gastric Cancer Based on CT Radiomics Prediction(LAGC) | enrolling by invitation | — | 900 | Liu YangOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT07686133 | Digital Education in Colorectal Cancer Patients(GUIDE) | enrolling by invitation | N/A | 100 | University Health Network, TorontoOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT07682883 | The Importance of Mucosal Screening in the Prevention of Oral Cancer. | enrolling by invitation | N/A | 1,383 | Medical University of WarsawOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT07683949 | Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine(LENCAP-CRC) | enrolling by invitation | Phase 1 / Phase 2 | 93 | Seoul National University Bundang HospitalOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT07139951 | Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence | enrolling by invitation | Phase 2 | 16 | Mayo ClinicOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07678047 | Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia | enrolling by invitation | N/A | 60 | Albert Einstein College of MedicineOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07673731 | Addressing Cancer-Related Distress Through Survivorship Care in Community Oncology | enrolling by invitation | N/A | 15 | Ellis MedicineOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT07499128 | Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event | enrolling by invitation | N/A | 136 | National Cancer Institute (NCI)NIH | 1 | Jun 25, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 7, 2026source: clinicaltrials